Skip to main content

Table 6 Antimicrobial susceptibility profile of Gram-negative bacteria isolated from participants with ocular and periocular infections study participants with infections at Shashemene Comprehensive Specialized Hospital Eye Unit, September 1, 2018 to March 30, 2019 (N = 63)

From: Bacterial etiology of ocular and periocular infections, antimicrobial susceptibility profile and associated factors among patients attending eye unit of Shashemene comprehensive specialized hospital, Shashemene, Ethiopia

Bacteria isolated

Antibiotic Pattern

Antibiotics

AMC

SXT

CIP

CRO

CN

CAF

TE

P

N. gonorrhoeae

n = 6

S

ND

ND

6 (100%)

6 (100%)

ND

ND

6 (100%)

6 (100%)

I

ND

ND

–

–

ND

ND

–

–

R

ND

ND

–

–

ND

ND

–

–

N. meningitidis n = 4

S

ND

4 (100%)

4 (100%)

4 (100%)

ND

2 (50.0%)

ND

ND

I

ND

–

–

–

ND

2 (50.0%)

ND

ND

R

ND

–

–

–

ND

–

ND

ND

Moraxella spp.

n = 8

S

6 (75.0%)

4 (50.0%)

7 (87.8%)

7 (87.8%)

7 (87.8%)

7 (87.8%)

6 (75.0%)

3 (37.5%)

I

1 (12.5%)

2 (25.0%)

–

–

–

1 (12.5%)

1 (12.5%)

–

R

1 (12.5%)

2 (25.0%)

1 (12.5%)

1 (22.2%)

1 (22.2%)

–

1 (12.5%)

5 (62.7%)

Pseudomonas spp.

n = 3

S

3 (100%)

–

3 (100%)

3 (100%)

–

3 (100%)

–

ND

I

–

–

–

–

3 (100%)

–

–

ND

R

–

3 (100%)

–

–

–

–

3 (100%)

ND

H. influenzae

n = 6

S

3 (50.0%)

4 (66.6%)

6 (100%)

6 (100%)

ND

6 (100%)

4 (66.6%)

ND

I

3 (50.0%)

1 (16.7%)

–

–

ND

–

–

ND

R

–

1 (16.7%)

–

–

ND

–

2 (33.3%)

ND

E. coli

n = 17

S

9 (52.9%)

5 (29.4%)

17 (100%)

15 (88.2%)

17 (100%)

14 (82.4%)

1 (5.9%)

ND

I

6 (35.3%)

1 (5.9%)

–

1 (5.9%)

–

1 (5.9%)

2 (11.8%)

ND

R

2 (11.8%)

11 (64.7%)

–

1 (5.9%)

–

2 (11.8%)

14 (82.4%)

ND

K. pneumoniae

n = 9

S

6 (66.7%)

6 (66.7%)

9 (100%)

9 (100%)

9 (100%)

8 (88.9%)

2 (22.2%)

ND

I

1 (11.1%)

–

–

–

–

1 (11.1%)

1 (11.1%)

ND

R

2 (22.2%)

3 (33.3%)

–

–

–

–

6 (66.7%)

ND

P. mirabilis

n = 3

S

–

3 (100%)

3 (100%)

3 (100%)

3 (100%)

3 (100%)

3 (100%)

ND

I

–

–

–

–

–

–

–

ND

R

3 (100%)

–

–

–

–

–

–

ND

Citrobacter spp.

n = 7

S

6 (85.7%)

6 (85.7%)

7 (100%)

7 (100%)

6 (85.7%)

4 (57.1%)

7 (100%)

ND

I

–

–

–

–

–

2 (28.6%)

–

ND

R

1 (14.3%)

1 (14.3%)

–

–

1 (14.3%)

1 (14.3%)

–

ND

  1. AMC Amoxicillin-clavulanic Acid, SXT Trimethoprim-sulphametoxazole, CIP Ciprofloxacin, CRO Ceftriaxone, CN Gentamicin, CAF Chloramaphenicol, TE Tetracycline, P Penicillin, ND Not Done. S Susceptible, I Intermediate, and R Resistance